
TherapeuticsMD, Inc.
NASDAQ:TXMD
Overview | Financials
Company Name | TherapeuticsMD, Inc. |
Symbol | TXMD |
Currency | USD |
Price | 1.46 |
Market Cap | 16,898,624 |
Dividend Yield | 0% |
52-week-range | 0.7 - 2.44 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Governor Thomas G. Thompson |
Website | https://www.therapeuticsmd.com |
An error occurred while fetching data.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD